UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009426
Receipt number R000011074
Scientific Title Examination for severe pruritus in head and neck cancer patients and development for effective treatment.
Date of disclosure of the study information 2012/12/04
Last modified on 2013/03/21 22:44:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination for severe pruritus in head and neck cancer patients and development for effective treatment.

Acronym

Examination for severe pruritus in head and neck cancer patients and development for effective treatment.

Scientific Title

Examination for severe pruritus in head and neck cancer patients and development for effective treatment.

Scientific Title:Acronym

Examination for severe pruritus in head and neck cancer patients and development for effective treatment.

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Dermatology Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the reason of pruritus in head and neck cancer patient who receive chemo-radiation therapy and evaluate the treatment and its efficacy. Especially, to investigate efficacy of ceramide cream for skin protection and moisturizer.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Moisturizing effect
Anti itch effect
Duratation of the effect
Days in hospital
Adverse event i.e. pain

Key secondary outcomes

Use of antiallergic agent
Completion rate of chemo-radiation therapy
Effect of cancer therapy


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

ceramide cream

Interventions/Control_2

Hildoid lotion

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patient age 20 years and above
2.Head and neck cancer after common therapy
3.Patients who have pruritus which does not disappear by existing treatment
4.Patients who were provided written informed consent

Key exclusion criteria

1.Possibility of the remarkabke phisical damage by this treatment
2.Patient judged by the investigator to be unfit to be enrolled into the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Junkichi Yokoyama

Organization

Juntendo university school of medicine

Division name

Department of Otolaryngology, head and neck surgery

Zip code


Address

3-1-1, Hongo, Bunkyou-ku, Tokyo

TEL

03-3813-3111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Junkichi Yokoyama

Organization

Juntendo university school of medicine

Division name

Department of Otolaryngology, head and neck surgery

Zip code


Address


TEL


Homepage URL


Email

gakujutu@juntendo.ac.jp


Sponsor or person

Institute

Juntendo university school of medicine

Institute

Department

Personal name



Funding Source

Organization

Research institute of environmental medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 11 Month 20 Day

Date of IRB


Anticipated trial start date

2012 Year 12 Month 04 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 11 Month 28 Day

Last modified on

2013 Year 03 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011074


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name